microRNA‑124‑3p inhibits the progression of congenital hypothyroidism via targeting programmed cell death protein 6

  • Authors:
    • Wenjie Li
    • Dongpo Song
    • Yingmei Sun
    • Yanan Lv
    • Jinfeng Lv
  • View Affiliations

  • Published online on: April 13, 2018     https://doi.org/10.3892/etm.2018.6062
  • Pages: 5001-5006
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The incidence of congenital hypothyroidism (CH) in newborn infants ranges from 1 in 3,000 to 1 in 4,000. Previous studies have indicated the neuroprotective role of microRNA (miR)‑124‑3p, however the expression and role of miR‑124‑3p in CH remain unclear. Therefore, the present study was performed to investigate the role and precise molecular mechanism of miR‑124‑3p in CH. Propylthiouracil (50 mg/day) was injected into the stomach of pregnant rats from gestational day 15 until parturition in order to establish a thyroid hypofunction model. Newborn rats were divided into the following four groups: The control group; the thyroid hypofunction group; the miR‑124‑3p mimic group; and the miR‑124‑3p negative control group. Reverse transcription‑quantitative polymerase chain reaction indicated that miR‑124‑3p was significantly decreased in the hippocampus of the thyroid hypofunction group compared with the control group. Bioinformatics software was used to predict mRNA targets recognized by miR‑124‑3p and the programmed cell death protein 6 (PDCD6) 3' untranslated region (UTR) was demonstrated to exhibit the seed sequence of miR‑124‑3p. The interaction between miRNA‑124‑3p and PDCD6 was then verified using a dual‑luciferase reporter assay system. PDCD6 expression was significantly increased in the hippocampus of rats with CH compared with the control group. Flow cytometry was performed to investigate the effects of miR‑124‑3p on neuronal cell apoptosis and the results indicated that the apoptosis rate in the thyroid hypofunction group was significantly increased compared with the control group; this increase was reversed by transfection with miR‑124‑3p mimics. Western blot analysis was used to detect the levels of cleaved poly [ADP‑ribose] polymerase (PARP), full‑length PARP, caspase‑3, B cell lymphoma‑2 (Bcl‑2) and Bcl‑2‑associated X protein (Bax) proteins. The results indicated that the expression of cleaved PARP, caspase‑3 and Bax protein were significantly increased and the expression of full‑length PARP and Bcl‑2 protein was significantly decreased compared with the control group. These effects were reversed by miRNA‑124‑3p mimic transfection. Taken together, the results of the present study demonstrate that miRNA‑124‑3p serves a protective role in CH via targeting PDCD6.
View Figures
View References

Related Articles

Journal Cover

June-2018
Volume 15 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li W, Song D, Sun Y, Lv Y and Lv J: microRNA‑124‑3p inhibits the progression of congenital hypothyroidism via targeting programmed cell death protein 6. Exp Ther Med 15: 5001-5006, 2018
APA
Li, W., Song, D., Sun, Y., Lv, Y., & Lv, J. (2018). microRNA‑124‑3p inhibits the progression of congenital hypothyroidism via targeting programmed cell death protein 6. Experimental and Therapeutic Medicine, 15, 5001-5006. https://doi.org/10.3892/etm.2018.6062
MLA
Li, W., Song, D., Sun, Y., Lv, Y., Lv, J."microRNA‑124‑3p inhibits the progression of congenital hypothyroidism via targeting programmed cell death protein 6". Experimental and Therapeutic Medicine 15.6 (2018): 5001-5006.
Chicago
Li, W., Song, D., Sun, Y., Lv, Y., Lv, J."microRNA‑124‑3p inhibits the progression of congenital hypothyroidism via targeting programmed cell death protein 6". Experimental and Therapeutic Medicine 15, no. 6 (2018): 5001-5006. https://doi.org/10.3892/etm.2018.6062